A clinical study to evaluate the feasibility and dose delivery accuracy of modified track Dynamic WaveArc therapy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1052200034

Enrollment

Registered

2020-07-08

Start date

2020-08-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer (left), Spinal metastases APBI, Spinal metastasis

Interventions

Radiotherpy with Dynamic Wave-arc method.

D011878

high-precision radiotherapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Left breast cancer, post surgery. spinal metastases less than 3 lesions.

Exclusion criteria

Exclusion criteria: Severe complications. Mental illness. Re-irradiation. Dose distribution of DWA is inferior to conventional radiotherapy

Design outcomes

Primary

Measure	Time frame
Completion of treatment protocol	—

Secondary

Measure	Time frame
Breast cancer : acute adverse event rate, late adverse event rate, recurrence-free survival in affected breast, breast aggravation, deterioration of breast cosmetic outcomes rate, disease-free survival, overall survival Spinal metastases : acute adverse event rate, late adverse event rate, local progression-free survival, recurrence-free survival, overall survival	—

Contacts

Public ContactKiyonao Nakamura

Kyoto University Hospital

kiyonaka@kuhp.kyoto-u.ac.jp+81-75-751-3762

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026